Anixa Biosciences Inc

ANIXNASDAQ · USD
2.71USD-0.08 (-3.05%)
225

Anixa Biosciences Inc (ANIX) Option Chain

As of September 22, 2026, Anixa Biosciences Inc is trading at $2.71, a -3.05% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 1,859.7%. IV Rank is 100%.

Read more

Tracking the ANIX option chain helps you see every strike and expiry on Anixa Biosciences Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Anixa Biosciences Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ANIX options activity at a glance. Use our scanner to monitor the ANIX option chain in real time and filter for the ANIX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ANIX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ANIX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ANIX stock options are being actively traded and where they are not.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer.

The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Anixa Biosciences Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ANIX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ANIX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile99.60% Elevated
  • Market cap (M$)97
  • 52 weeks high-48.90%
  • 52 weeks low20.26%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$8.33
    220.52% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-06-05
  • P/E
  • Future P/E
  • EPS (ttm)-0.31
  • EPS growth next 5 years0.29%

As of September 22, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
50.095250.270.210.050.902.50-9.750.350.000.3505849.91
93.371,11530.100.000.105.00+80.510.502.502.29-0.790336.63
99.141902.800.002.807.50+170.762.906.604.79-0.040420.86

As of September 22, 2026

Scan the full option chain in one place

Browse the full ANIX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial